Side Effects of Drugs Annual

Side Effects of Drugs Annual

A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions

1st Edition - May 9, 2007

Write a review

  • Editor: Jeffrey K. Aronson
  • eBook ISBN: 9780080522814

Purchase options

Purchase options
DRM-free (Mobi, EPub, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the Annuals by selecting critically from each year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.

Key Features

  • Provides a critical yearly survey of new data and trends
  • Includes an essay that describes the modern approach to classifying adverse drug reactions
  • Special reviews in this Annual include, among other topics: Antipsychotic drugs and now-onset diabetes mellitus, Treating asthma during pregnancy, and MMR vaccine and autism

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, Clinical pharmacologists, and medical libraries

Table of Contents

  • Contributors

    Special reviews

    Cumulative index of special reviews, Annuals 14–28

    Table of Essays, Annuals 1–28

    DoTS classification of adverse drug reactions

    How to use this book

    Data mining in drug safety

    1 Central nervous system stimulants and drugs that suppress appetite

    Methylxanthines (SEDA-26, 1; SEDA-27, 1; SEDA-28, 1)

    Amphetamines (SED-15, 180; SEDA-26, 30; SEDA-27, 29; SEDA-28, 4, 28)

    Drugs that suppress appetite (SEDA-26, 6; SEDA-27, 4; SEDA-28, 6)

    Drugs used in Alzheimer's disease (SEDA-26, 7; SEDA-27, 7; SEDA-28, 9)

    2 Antidepressant drugs

    Mania as an adverse effect of antidepressants

    Monoamine oxidase inhibitors (SED-15, 2371; SEDA-24, 12)

    Tricyclic antidepressants (SED-15, 3489; SEDA-26, 11; SEDA-27, 11; SEDA-28, 15)

    Selective serotonin re-uptake inhibitors (SSRIs) (SED-15, 3109; SEDA-26, 11; SEDA-27, 12; SEDA-28, 15)

    Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

    Other antidepressants

    3 Lithium

    4 Drugs of abuse

    Cannabinoids (SED-15, 614; SEDA-26, 36; SEDA-27, 32; SEDA-28, 36)

    Cocaine (SED-15, 848; SEDA-26, 27; SEDA-27, 33; SEDA-28, 38; see also Chapter 11)

    Opioid analgesics (SED-15, 2619; SEDA-27, 38; SEDA-28, 44)

    5 Hypnosedatives and anxiolytics

    Azaspirones (SEDA-26, 49; SEDA-27, 43; SEDA-28, 52)

    Benzodiazepines (SED-15, 429; SEDA-26, 46; SEDA-27, 43; SEDA-28, 52)

    Other hypnotics and sedatives

    6 Antipsychotic drugs

    General (SED-15, 2438)

    Individual drugs

    7 Antiepileptic drugs

    8 Opioid analgesics and narcotic antagonists

    Opioid receptor agonists

    Partial opioid receptor agonists

    Opioid receptor antagonists

    Miscellaneous compounds

    9 Anti-inflammatory and antipyretic analgesics and drugs used in gout

    Coxibs and cardiovascular disease

    Individual drugs and classes

    Arylalkanoic acid derivatives (SED-15, 2555; SEDA-26, 115; SEDA-27, 115; SEDA-28, 126)

    Oxicams (SEDA-15, 2555; SEDA-27, 116; SEDA-28, 128)

    Drugs used in the treatment of gout

    10 General anesthetics and therapeutic gases

    Sedation in special circumstances

    Anesthetic vapors (SED-15, 1489; SEDA-26, 132; SEDA-27, 119; SEDA-28, 139)

    Nitrous oxide (SED-15, 2550; SEDA-27, 120; SEDA-28, 140)

    Xenon (SED-15, 3693; SEDA-27, 120; SEDA-28, 140)

    Intravenous agents. Miscellaneous non-barbiturate anesthetics

    11 Local anesthetics

    General topics (SED-15, 2116)

    Effects related to modes of use (SED-15, 2121)

    Individual compounds

    12 Neuromuscular blocking agents and skeletal muscle relaxants

    Anaphylaxis due to neuromuscular blocking agents

    Skeletal muscle relaxants (SEDA-26, 152; SEDA-27, 141; SEDA-28, 157)

    13 Drugs that affect autonomic functions or the extrapyramidal system

    Drugs that stimulate both alpha- and beta-adrenoceptors (SEDA-26, 156; SEDA-27, 145; SEDA-28, 160)

    Drugs that predominantly stimulate alpha1-adrenoceptors (SEDA-26, 157; SEDA-27, 147; SEDA-28, 161)

    Drugs that stimulate beta1-adrenoceptors (SEDA-26, 159; SEDA-27, 147)

    Drugs that stimulate dopamine receptors (SEDA-26, 159; SEDA-27, 148; SEDA-28, 162)

    Other drugs that increase dopamine activity (SEDA-26, 162; SEDA-27, 151; SEDA-28, 164)

    Drugs that affect the cholinergic system (SEDA-26, 164; SEDA-27, 152; SEDA-28, 165)

    14 Dermatological drugs, topical agents, and cosmetics

    Contact allergens

    Photochemotherapy (SED-15, 2823; SEDA-28, 171)

    Vitamin A (Retinoids) (SED-15, 3653; SEDA-27, 159; SEDA-28, 171; for vitamin A carotenoids see Chapter 34)

    15 Antihistamines (H1 receptor antagonists)

    16 Drugs acting on the respiratory tract

    Inhaled glucocorticoids (SED-15, 958; SEDA-26, 186; SEDA-27, 174; SEDA-28, 184)

    Beta2-adrenoceptor agonists (SED-15, 448; SEDA-26, 190; SEDA-27, 179; SEDA-28, 188)

    Anticholinergic drugs (SED-15, 264; SEDA-26, 194; SEDA-27, 180; SEDA-28, 190)

    Leukotriene modifiers (SED-15, 2025; SEDA-26, 193; SEDA-27, 177; SEDA-28, 191)

    Combinations of drugs

    17 Positive inotropic drugs and drugs used in dysrhythmias

    Cardiac glycosides (SED-15, 648; SEDA-26, 198; SEDA-27, 185; SEDA-28, 196)

    Other positive inotropic drugs (SED-15, 2822; SEDA-26, 201; SEDA-27, 188; SEDA-28, 199)

    Drugs used in dysrhythmias

    18 Beta-adrenoceptor antagonists and antianginal drugs

    Beta-adrenoceptor antagonists (SED-15, 452; SEDA-26, 223; SEDA-27, 203; SEDA-28, 217)

    Nitrates, organic (SED-15, 2529; SEDA-26, 224; SEDA-27, 204; SEDA-28, 218)

    Calcium channel blockers (SED-15, 598; SEDA-26, 225; SEDA-27, 224; SEDA-28, 218)

    19 Drugs acting on the cerebral and peripheral circulations

    Drugs used in the treatment of arterial disorders of the brain and limbs

    Drugs used in the treatment of venous disorders

    Drugs used in the treatment of migraine

    Other peripheral vasodilators

    20 Antihypertensive drugs

    Moving targets and patterns of prescribing

    Angiotensin converting enzyme inhibitors (SED-15, 226; SEDA-26, 234; SEDA-27, 213; SEDA-28, 227)

    Angiotensin II receptor antagonists (SED-15, 223; SEDA-26, 236; SEDA-27, 214; SEDA-28, 229)

    Endothelin receptor antagonists (SED-15, 1215; SEDA-26, 233; SEDA-27, 214)

    Drugs that act on the sympathetic nervous system (SEDA-27, 216; SEDA-28, 230)

    Imidazoline receptor antagonists

    Direct vasodilators

    21 Diuretics

    Hyponatremia and loop and thiazide diuretics

    Urinary tract

    Carbonic anhydrase inhibitors (SED-15, 643; SEDA-26, 238; SEDA-27, 220; SEDA-28, 233)

    Thiazide diuretics (SED-15, 3375; SEDA-26, 239; SEDA-27, 220; SEDA-28, 233)

    Loop diuretics (SED-15, 567, 1454; SEDA-26, 239; SEDA-27, 220; SEDA-28, 233)

    Aldosterone receptor antagonists

    Osmotic diuretics

    22 Metals

    23 Metal antagonists

    Iron chelators

    Penicillamine and related drugs

    Polystyrene sulfonates (SED-15, 2894; SEDA-26, 256; SEDA-27, 236; SEDA-28, 259)

    24 Antiseptic drugs and disinfectants

    Bisbiguanides

    Iodophors (SEDA-15, 1896; SEDA-27, 240; SEDA-28, 262)

    25 Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines

    Antimicrobial drug resistance: a serious adverse effect exemplified by avoparcin and vancomycin-resistant enterococci

    Beta-lactam antibiotics (SED-15, 478; SEDA-26, 279; SEDA-27, 242; SEDA-28, 267)

    Carbapenems (SED-15, 638; SEDA-26, 265; SEDA-27, 246)

    Cephalosporins (SED-15, 688; SEDA-26, 264; SEDA-27, 245; SEDA-28, 268)

    Monobactams (SED-15, 2378; SEDA-27, 247)

    Penicillins (SED-15, 2756; SEDA-26, 262; SEDA-27, 244)

    Tetracyclines (SED-15, 3330; SEDA-26, 265; SEDA-27, 247; SEDA-28, 270)

    Glycylcyclines

    26 Miscellaneous antibacterial drugs

    Aminoglycoside antibiotics (SED-15, 118; SEDA-26, 271; SEDA-27, 251; SEDA-28, 274)

    Chloramphenicol and related drugs (SED-15, 706; SEDA-26, 273; SEDA-26, 274; SEDA-26, 276)

    Fluoroquinolones (SED-15, 1396; SEDA-26, 274; SEDA-27, 254; SEDA-28, 276)

    Fusidic acid (SED-15, 1460; SEDA-26, 281; SEDA-27, 259; SEDA-28, 280)

    Glycopeptides (SEDA-26, 281; SEDA-27, 259; SEDA-28, 280)

    Ketolides (SED-15, 1976; SEDA-26, 283; SEDA-27, 260; SEDA-28, 281)

    Lincosamides (SED-15, 2063; SEDA-26, 283; SEDA-27, 260; SEDA-28, 281)

    Macrolide antibiotics (SED-15, 2183; SEDA-26, 284; SEDA-27, 261; SEDA-28, 282)

    Nitrofurantoin (SED-15, 2542; SEDA-26, 288; SEDA-27, 264; SEDA-28, 284)

    Oxazolidinones (SED-15, 2645; SEDA-26, 288; SEDA-27, 264; SEDA-28, 284)

    Polymyxins (SED-15, 2891; SEDA-26, 289; SEDA-27, 265; SEDA-28, 285)

    Streptogramins (SED-15, 3182; SEDA-26, 289; SEDA-27, 265; SEDA-28, 285)

    Sulfonamides, trimethoprim, and co-trimoxazole (SED-15, 3216, 3510; SEDA-26, 290; SEDA-27, 266; SEDA-28, 285)

    Other antimicrobial drugs

    27 Antifungal drugs

    Allylamines (SEDA-26, 309; SEDA-27, 284; SEDA-28, 294)

    Amphotericin (SED-15, 192; SEDA-26, 302; SEDA-27, 276; SEDA-28, 295)

    Antifungal azoles (SED-15, 301; SEDA-26, 304; SEDA-27, 278; SEDA-28, 299)

    Echinocandins (SED-15, 1197; SEDA-26, 311; SEDA-28, 309)

    28 Antiprotozoal drugs

    Antimalarial drugs

    4-Aminoquinolines (chloroquine and congeners) (SEDA-26, 315; SEDA-27, 289; SEDA-28, 315)

    Pyrimethamine and combinations (SED-15, 2984; SEDA-26, 320; SEDA-27, 293; SEDA-28, 318)

    Quinine and congeners (SED-15, 3002; SEDA-26, 318; SEDA-27, 290)

    Endoperoxides

    Drugs used in the treatment of pneumocystis jiroveci infections (SEDA-26, 320; SEDA-27, 295; SEDA-28, 322)

    29 Antiviral drugs

    Drugs active against cytomegalovirus

    Drugs active against herpesviruses (SEDA-26, 329; SEDA-27, 305; SEDA-28, 328)

    Drugs active against hepatitis viruses

    Drugs active against human immunodeficiency virus: nucleoside analogue reverse transcriptase inhibitors (NRTI) (SED-15, 2586; SEDA-26, 330; SEDA-27, 306; SEDA-28, 332)

    Drugs active against human immunodeficiency virus: nucleotide analogue reverse transcriptase inhibitors

    Drugs active against human immunodeficiency virus: non-nucleoside reverse transcriptase inhibitors (NNRTI) (SED-15, 2553; SEDA-27, 308; SEDA-28, 334)

    Drugs active against human immunodeficiency virus: protease inhibitors (SED-15, 2965; SEDA-26, 332; SEDA-28, 335)

    Drugs active against human immunodeficiency virus: inhibitors of HIV fusion

    Drugs active against influenza viruses: neuraminidase inhibitors (SED-15, 2436; SEDA-26, 334; SEDA-27, 317; SEDA-28, 337)

    30 Drugs used in tuberculosis and leprosy

    Immune reconstitution disease

    31 Antihelminthic drugs

    Artemisinin derivatives (SED-15, 342; SEDA-26, 319; SEDA-27, 292; SEDA-28, 320)

    Benzimidazoles (SED-15, 424; SEDA-25, 367; SEDA-26, 344; SEDA-27, 326)

    32 Vaccines

    Bacterial vaccines

    Viral vaccines

    33 Blood, blood components, plasma, and plasma products

    Albumin (SED-15, 54; SEDA-28, 371)

    Anticoagulant proteins (SED-15, 266; SEDA-28, 371)

    Blood transfusion (SED-15, 529; SEDA-28, 369)

    Blood substitutes (SEDA-28, 370)

    Plasma products (SED-15, 2847)

    Plasma substitutes (SEDA-26, 374; SEDA-27, 353; SEDA-28, 371)

    Globulins

    Coagulation proteins (SED-15, 845; SEDA-28, 375)

    Erythropoietin and derivatives (SED-15, 1243)

    Stem cells

    34 Formulations used in nutrition

    Parenteral nutrition (SED-15, 2700; SEDA-26, 377; SEDA-27, 355; SEDA-28, 383)

    Vitamins of the B group (SEDA-26, 419; SEDA-27, 407; SEDA-28, 387)

    Vitamin D Analogues (SED-15, 3669; SEDA-28, 388)

    Vitamin E (SED-15, 3677)

    35 Drugs affecting blood coagulation, fibrinolysis, and hemostasis

    Coumarin anticoagulants (SED-15, 983; SEDA-26, 379; SEDA-27, 358; SEDA-28, 391)

    Heparins (SED-15, 1590; SEDA-26, 379; SEDA-27, 358; SEDA-28, 391)

    Thrombolytic agents (SED-15, 3402; SEDA-28, 392)

    Short polysaccharide inhibitors of coagulating factors (SEDA-27, 359; SEDA-28, 392)

    Direct thrombin inhibitors (SED-15, 1142; SEDA-27, 359)

    Drugs that alter platelet function (SEDA-25, 412; SEDA-26, 380; SEDA-27, 360; SEDA-28, 396)

    Hemostatic agents

    36 Gastrointestinal drugs

    Antiemetics and drugs that affect gastrointestinal motility

    5-HT3 receptor antagonists (SED-15, 1365; SEDA-26, 382; SEDA-27, 363; SEDA-28, 402)

    Histamine H2 receptor antagonists (SED-15, 1629; SEDA-26, 384; SEDA-27, 363; SEDA-28, 403)

    Proton pump inhibitors (SED-15, 2973; SEDA-26, 384; SEDA-27, 364; SEDA-28, 403)

    Antidiarrheal agents (SEDA-27, 367; SEDA-28, 406)

    Laxatives and oral bowel preparations (SED-15, 2008; SEDA-26, 387; SEDA-27, 367; SEDA-28, 406)

    Aminosalicylates (SED-15, 138; SEDA-26, 387; SEDA-27, 367; SEDA-28, 408)

    Bile acids (SED-15, 515; SEDA-26, 389; SEDA-27, 369; SEDA-28, 409)

    Prebiotics

    Other gastrointestinal agents

    37 Drugs that act on the immune system: cytokines and monoclonal antibodies

    Colony-stimulating factors (SEDA-26, 398; SEDA-27, 391; SEDA-28, 415)

    Interferons (SED-15, 1841; SEDA-26, 393; SEDA-27, 383; SEDA-28, 416)

    Interleukins (SED-15, 1842; SEDA-26, 397; SEDA-27, 390; SEDA-28, 424)

    Tumor necrosis factor (TNF) antagonists (SEDA-26, 399; SEDA-27, 393; SEDA-28, 425)

    Monoclonal antibodies (SED-15, 2380; SEDA-26, 402; SEDA-27, 378; SEDA-28, 434)

    38 Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs

    Immunosuppressive drugs

    Immunoenhancing drugs

    Other drugs

    39 Corticotrophins, corticosteroids, and prostaglandins

    Systemic glucocorticoids (SED-15, 906; SEDA-26, 427; SEDA-27, 414; SEDA-28, 471)

    Nasal glucocorticoids

    Intra-articular glucocorticoids

    Prostaglandins and analogues (SED-15, 2955; SEDA-26, 430; SEDA-27, 417; SEDA-28, 476)

    40 Sex hormones and related compounds, including hormonal contraceptives

    Gonadotropins and ovulation-inducing drugs (SED-15, 1536; SEDA-26, 434; SEDA-27, 420; SEDA-28, 480)

    Estrogens (SED-15, 1253; SEDA-26, 436; SEDA-27, 422; SEDA-28, 481)

    Hormonal contraceptives (SED-15, 1642 et seq; SEDA-26, 442; SEDA-27, 426; SEDA-28, 487)

    Antiestrogens and selective estrogen receptor modulators (SERMs) (SEDA-26, 445; SEDA-27, 429; SEDA-28, 490)

    Progestogens (SED-15, 2930; SEDA-26, 447; SEDA-27, 433; SEDA-28, 493)

    Progesterone antagonists (SEDA-26, 448; SEDA-27, 433; SEDA-28, 494)

    Anabolic steroids, androgens, and related compounds (SED-15, 216; SEDA-26, 449; SEDA-27, 434; SEDA-28, 495)

    Antiandrogens (SEDA-26, 451; SEDA-27, 435; SEDA-28, 497)

    Miscellaneous compounds

    41 Thyroid hormones and antithyroid drugs

    THYROID HORMONES (SED-15, 3409; SEDA-26, 45; SEDA-27, 442; SEDA-28, 505)

    Antithyroid drugs (SED-15, 3387; SEDA-26, 458; SEDA-27, 442; SEDA -28, 506)

    42 Insulin, other hypoglycemic drugs, and glucagon

    Insulin (SED-15, 1761; SEDA-26, 461; SEDA-27, 446; SEDA-28, 509)

    New ultrashort-acting insulins (SEDA-26, 463; SEDA-27, 449; SEDA-28, 512)

    Long-acting insulins (SEDA-26, 463; SEDA-27, 450; SEDA-28, 513)

    Alpha glucosidase inhibitors (SED-15, 85; SEDA-26, 466; SEDA-27, 452; SEDA-28, 514)

    Amylin analogues (SEDA-27, 453; SEDA-28, 514)

    Biguanides (SED-15, 506; SEDA-26, 467; SEDA-27, 453; SEDA-28, 514)

    Meglitinides (SED-15, 2238; SEDA-26, 468; SEDA-27, 455; SEDA-28, 518)

    Sulfonylureas (SED-15, 3230; SEDA-26, 469; SEDA-27, 456; SEDA-28, 518)

    Thiazolidinediones (glitazones) (SED-15, 3380; SEDA-26, 471; SEDA-27, 457; SEDA-28, 519)

    Combinations of oral hypoglycemic drugs

    43 Miscellaneous hormones

    Somatostatin (growth hormone release-inhibiting hormone) and analogues (SED-15, 3160; SEDA-26, 480; SEDA-27, 467; SEDA-28, 530)

    Vasopressin and analogues (SED-15, 3609; SEDA-26, 482; SEDA-27, 469; SEDA-28, 531)

    44 Drugs that affect lipid metabolism

    45 Cytostatic drugs

    General

    46 Radiological contrast agents

    Types of contrast agents

    MRI contrast media

    47 Drugs used in ocular treatment

    Intravitreal and parabulbar injection of drugs

    Ocular dyes

    48 Treatments used in complementary and alternative medicine

    Herbal medicines (SED-15, 1609; SEDA-26, 528; SEDA-27, 512; SEDA-28, 573)

    Non-herbal supplements

    Acupuncture (SED-15, 890; SEDA-26, 535; SEDA-27, 520; SEDA-28, 581)

    Colonic irrigation

    Homeopathy (SED-15, 892; SEDA-28, 582)

    Spinal manipulation (SED-15, 893; SEDA-26, 536; SEDA-27, 521; SEDA-28, 582)

    49 Miscellaneous drugs and materials, medical devices, and techniques

    Dyestuffs

    Medical devices

    49 Miscellaneous drugs and materials, medical devices, and techniques

    Address list of national centres that participate in the WHO Drug Monitoring Programme

    Index of drugs

    Index of adverse effects

Product details

  • No. of pages: 714
  • Language: English
  • Copyright: © Elsevier Science 2007
  • Published: May 9, 2007
  • Imprint: Elsevier Science
  • eBook ISBN: 9780080522814

About the Editor

Jeffrey K. Aronson

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.

Affiliations and Expertise

Department of Primary Health Care, University of Oxford, Oxford, UK

Ratings and Reviews

Write a review

There are currently no reviews for "Side Effects of Drugs Annual"